Canada - English - Health Canada

pro doc limitee - rivaroxaban - tablet - 20mg - rivaroxaban 20mg

Canada - English - Health Canada

pharmascience inc - rivaroxaban - tablet - 2.5mg - rivaroxaban 2.5mg - direct factor xa inhibitors

Canada - English - Health Canada

pharmascience inc - rivaroxaban - tablet - 15mg - rivaroxaban 15mg - direct factor xa inhibitors

Canada - English - Health Canada

pharmascience inc - rivaroxaban - tablet - 20mg - rivaroxaban 20mg - direct factor xa inhibitors

Canada - English - Health Canada

pharmascience inc - rivaroxaban - granules for suspension - 51.7mg - rivaroxaban 51.7mg - direct factor xa inhibitors

Canada - English - Health Canada

pharmascience inc - rivaroxaban - granules for suspension - 103.4mg - rivaroxaban 103.4mg - direct factor xa inhibitors

Malta - English - Malta Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - rivaroxaban - film-coated tablet - rivaroxaban 10 mg - antithrombotic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - rivaroxaban, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium lauryl sulfate; croscarmellose sodium; hypromellose; lactose monohydrate; iron oxide red; titanium dioxide; macrogol 3350; magnesium stearate - xarelto is indicated for: ? prevention of venous thromboembolism (vte) in adult patients who have undergone major orthopaedic surgery of the lower limbs (elective total hip replacement, treatment for up to 5 weeks; elective total knee replacement, treatment for up to 2 weeks) ? prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke ? treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe) and for the prevention of recurrent dvt and pe,xarelto, in combination with aspirin, is indicated for ? the prevention of major cardiovascular events (composite of stroke, myocardial infarction and cardiovascular death) in patients with coronary artery disease (cad) and/or peripheral artery disease (pad).

Canada - English - Health Canada

sivem pharmaceuticals ulc - rivaroxaban - tablet - 10mg - rivaroxaban 10mg

Israel - English - Ministry of Health

bayer israel ltd - rivaroxaban - film coated tablets - rivaroxaban 10 mg - rivaroxaban - rivaroxaban - prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.prevention of recurrent deep vein thrombosis (dvt) and pulmonary embolism (pe), adults (following completion of at least 6 months therapy for dvt or pe).